The Proatherogenic Role of T Cells Requires Cell Division and Is Dependent on the Stage of the Disease

Author:

Khallou-Laschet Jamila1,Caligiuri Giuseppina1,Groyer Emilie1,Tupin Emanuel1,Gaston Anh-Thu1,Poirier Bruno1,Kronenberg Mitchell1,Cohen José L.1,Klatzmann David1,Kaveri Srini V.1,Nicoletti Antonino1

Affiliation:

1. From the INSERM U681 (J.K-L., G.C., E.G., E.T., A-T.G., B.P., S.V.K., A.N.), Institut des Cordeliers/Université Paris 6 UPMC, Paris, France; Division of Developmental Immunology (E.T., M.K.), La Jolla Institute for Allergy and Immunology, San Diego, Calif; and Centre National de la Recherche Scientifique–Unité Mixte de Recherche 7087 (J.L.C., D.K.), Hôpital Pitié-Salpétrière, Paris, France.

Abstract

Objective— The mechanism by which T cells exert a proatherogenic potential is unclear. In order to determine whether this potential requires their replication, we crossed atherosclerosis-prone apolipoprotein E knockout mice (ApoE°) with transgenic mice in which exclusive and conditional ablation of dividing T cells relies on their specific expression of the herpes simplex type 1 thymidine kinase (TK) suicide gene. Methods and Results— We first showed that conalbumin-immunized ApoE°TK mice mounted a significant immune response to the antigen that was fully and specifically blocked by an in vivo ganciclovir (GCV) treatment. Next, ApoE°TK mice and ApoE° mice were treated or not with GCV either during the first 4 weeks (GCV 1 to 4w), the last 4 weeks (GCV 5 to 8w), or during 8 weeks (GCV 1 to 8w). Strikingly, ApoE°TK mice displayed a dramatic decrease in lesion development in the GCV 1 to 8w and GCV 5 to 8w groups, whereas the GCV had no effect when administered during the first 4 weeks. In protected mice, the inflammatory parameters in lesions, the percentage of CD69 + CD3 + splenocytes, and the circulating natural killer T cells were reduced. Conclusions— The present study, therefore, shows that the proatherogenic potential of T cells is crucial in the progression of fatty streaks to mature plaques and requires cell division.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3